TELA Bio
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. TELA Bio's past years’ income statements indicate that its last revenue has increased compared to the previous period by 41% to $58,453,000. Profit margin reached -80%. Total operating expenses were $84,187,000.
Profit Margin
| 2017 | 4.24M | -21.33M | -502.57% |
|---|---|---|---|
| 2018 | 8.27M | -21.09M | -254.92% |
| 2019 | 15.44M | -25.80M | -167.05% |
| 2020 | 18.21M | -31.87M | -175.03% |
| 2021 | 29.46M | -36.11M | -122.56% |
| 2022 | 41.41M | -44.33M | -107.05% |
| 2023 | 58.45M | -46.66M | -79.83% |
TELA Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 58.45M | 41.41M | 29.46M | 18.21M | 15.44M | 8.27M | 4.24M |
Cost of revenue | 18.34M | 14.37M | 10.65M | 6.97M | 6.17M | 5.33M | 1.71M |
Gross profit | 40.11M | 27.04M | 18.81M | 11.23M | 9.27M | 2.94M | 2.53M |
Operating exp. | |||||||
Research and development | 9.61M | 8.93M | 6.74M | 4.25M | 4.15M | 4.33M | 5.78M |
Selling and marketing | 59.68M | 43.25M | 29.06M | 22.11M | 18.06M | 13.64M | 8.71M |
Total operating expenses | 84.18M | 66.05M | 48.26M | 36.50M | 28.43M | 22.88M | 19.45M |
Operating income | -44.07M | -39.00M | -29.45M | -25.27M | -19.16M | -17.78M | -16.92M |
Other income (expenses), net | -2.58M | -5.28M | -3.82M | -3.51M | -3.26M | 652K | -4.41M |
Income before tax | -46.66M | -44.29M | -33.27M | -28.79M | -22.42M | -21.09M | -21.33M |
Income tax expense | 0 | 41K | 2.83M | 3.08M | 3.37M | -1.50M | 4.65M |
Net income | -46.66M | -44.33M | -36.11M | -31.87M | -25.80M | -21.09M | -21.33M |
Earnings per share | |||||||
Basic EPS | -2.04 | -2.73 | -2.49 | -2.46 | -2.26 | -3.25 | -3.29 |
Diluted EPS | -2.04 | -2.73 | -2.49 | -2.46 | -2.26 | -3.25 | -3.29 |
| Data source | Data source | Data source | Data source | Data source |